Uniject is a revolutionary new injection method. The idea behind Uniject is that it would be so simple to use, that even untrained health workers would be able to safely and effectively give injections. This idea would allow for prepackaged, low-cost syringes. Not only would Uniject provide a safer and more cost efficient method of administering vaccines, it would also cut down drastically on the amount of wasted vaccines. The new syringes would not be able to be reused, also eliminating the chance of HIV transmission.
Uniject is an autodisable injection system created by PATH in Seattle. It is essentially a small bubble of plastic connected to a needle that contains whatever vaccine is desired. Health workers would be able to learn how to use this within two hours of training. The plastic bubble contains exactly one injection of vaccine, ensuring the correct dosage every single time.
PATH developed Uniject through funding from the US Agency for International Development. The idea has since been licensed to BD, which is the largest producer of syringes in the world. As part of this agreement, the technology must be given to pharmaceutical producers at preferential pricing for use in developing country programs. The development of Uniject has taken twenty years.
While Uniject was developed with the idea of providing low-cost effective syringes for use of vaccinations in developing countries, it also has the potential to help reduce poverty in other ways. Uniject could, down the road, also be used for other life saving drugs, as well as a potential contraception delivery method. The use of Uniject to deliver contraception could have an immense effect on the developing world and provide an extraordinarily important outlet for female empowerment and family planning in the developing world.